LON:POLB Poolbeg Pharma (POLB) Share Price, News & Analysis GBX 12.47 -0.18 (-1.40%) (As of 12:32 PM ET) Add Compare Share Share Today's Range 12.15▼ 12.8050-Day Range 12.20▼ 14.2552-Week Range 6.38▼ 15.77Volume3.93 million shsAverage Volume2.02 million shsMarket Capitalization£62.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get Poolbeg Pharma alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Poolbeg Pharma Stock (LON:POLB)Poolbeg Pharma plc operates as a biopharmaceutical company in the United Kingdom. It develops POLB 001, a p38 MAP Kinase inhibitor for the treatment of severe influenza; POLB 002, an inlicensed firstinclass broad spectrum RNAbased immunotherapy for respiratory virus infections; and POLB 003, an intramuscular vaccine to prevent Melioidosis. The company also has a licensed access to micro and nanoencapsulation technology to develop an oral vaccine delivery platform that delivers immune stimulating antigens to various areas of the gut; and artificial intelligence powered drug program. In addition, it is involved in the development of biomarker platform to identify those at risk of developing severe disease; and vaccine discovery platform, a model-derived discovery platform to identify new vaccine candidates. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.Read More POLB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart POLB Stock News HeadlinesJuly 26 at 5:23 AM | finance.yahoo.comPoolbeg Pharma PLC Announces Voluntary Delisting from OTCQB MarketMay 15, 2024 | msn.comThis 13p penny stock’s on fire! Should I buy it?July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 1, 2024 | lse.co.ukPoolbeg Pharma celebrates full patent approval for Immunomodulator IIMay 1, 2024 | finance.yahoo.comPoolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drugMay 1, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USAApril 30, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023April 29, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces TR-1: Notification of Major HoldingsJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.March 27, 2024 | finance.yahoo.comFavourable Signals For Poolbeg Pharma: Numerous Insiders Acquired StockMarch 20, 2024 | proactiveinvestors.comPoolbeg Pharma moves closer to locking down IP protection for key...February 22, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Director/PDMR ShareholdingFebruary 20, 2024 | finance.yahoo.comPoolbeg Pharma chair discusses shift to executive role; hVIVO share saleFebruary 19, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Director Share PurchaseFebruary 15, 2024 | finance.yahoo.comWe Think Poolbeg Pharma (LON:POLB) Can Afford To Drive Business GrowthFebruary 15, 2024 | msn.comPoolbeg Pharma announces board role change and launch of EIPFebruary 15, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Board Role Change and Launch of EIPFebruary 12, 2024 | finance.yahoo.comPoolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapiesSee More Headlines Receive POLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Poolbeg Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:POLB CUSIPN/A CIKN/A Webwww.poolbegpharma.com Phone44 20 7183 1499FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-3,930,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-24.00% Return on Assets-18.14% Debt Debt-to-Equity RatioN/A Current Ratio13.69 Quick Ratio47.96 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 5.92 per share Price / Cash Flow2.11 Book ValueGBX 3 per share Price / Book4.16Miscellaneous Outstanding Shares500,000,000Free FloatN/AMarket Cap£62.37 million OptionableNot Optionable Beta2.16 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Cathal Martin Friel (Age 60)Executive Chairman of The Board Comp: $138kDr. Jeremy Skillington Ph.D. (Age 53)CEO & Director Comp: $310kMr. Ian O'Connell (Age 37)CFO & Director Comp: $220kCarol DaltonVice President of Investor Relations & Public RelationsMr. John McEvoySenior Vice President & Chief Legal OfficerMr. David James Allmond (Age 54)Chief Business Officer Mr. Salim Gulamabbas Hamir F.C.A.Company SecretaryMr. Ross CrockettGroup Financial ControllerMore ExecutivesKey CompetitorsAvacta GroupLON:AVCTVerona Pharma plc (VRP.L)LON:VRPBioventixLON:BVXPhVIVOLON:HVO4basebioLON:4BBView All CompetitorsInsidersJeremy SkillingtonBought 154,764 shares on 2/21/2024Total: £1.70 M ($11.00/share)Cathal FrielBought 830,000 shares on 2/19/2024Total: £9.96 M ($12.00/share)View All Insider Transactions POLB Stock Analysis - Frequently Asked Questions How have POLB shares performed this year? Poolbeg Pharma's stock was trading at GBX 9.05 at the beginning of the year. Since then, POLB stock has increased by 37.8% and is now trading at GBX 12.47. View the best growth stocks for 2024 here. How do I buy shares of Poolbeg Pharma? Shares of POLB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:POLB) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Poolbeg Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
